Literature DB >> 22250083

Cutting edge: IL-21 derived from human follicular helper T cells acts as a survival factor for secondary lymphoid organ, but not for bone marrow, plasma cells.

Beatriz Rodríguez-Bayona1, Ana Ramos-Amaya, Jesús Bernal, Antonio Campos-Caro, José A Brieva.   

Abstract

IL-21 induces the differentiation of activated B lymphocytes into plasma cells (PC), but its direct effect on PC remains uncertain. This study analyzes the role of IL-21 on human in vivo-generated PC. IL-21R was clearly expressed on PC from the human tonsil, the lymph node, and the spleen (secondary lymphoid organs [SLO]) but barely on terminally mature bone marrow PC. IL-21 enhanced Ig secretion by isolated SLO PC but not bone marrow PC. Tonsillar T follicular helper (Tfh) lymphocytes are known to secrete IL-21. Purified Tfh cells induced a marked increase of Ig production by tonsillar PC, and this effect was impaired when endogenous IL-21 production was blocked. IL-21 provoked a rapid and transient phosphorylation of STAT3 in tonsillar PC. Tfh cells or exogenous IL-21 reduce tonsillar PC apoptosis and increases PC recovery but does not modify their nonproliferating status. These results suggest that IL-21 derived from Tfh cells acts as a survival factor for SLO PC in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22250083     DOI: 10.4049/jimmunol.1102786

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Interleukin-21: a double-edged sword with therapeutic potential.

Authors:  Rosanne Spolski; Warren J Leonard
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

2.  Elevated follicular helper T cells and expression of IL-21 in thyroid tissues are involved in the pathogenesis of Graves' disease.

Authors:  Jin Zhang; Meng Ren; Hua Zeng; Ying Guo; Zhenwu Zhuang; Zhimei Feng; Haiyan Yan; Mingtong Xu; Weiwen Liang; Chuan Yang; Hua Cheng; Helin Ding; Li Yan
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

3.  Natural allelic variation of the IL-21 receptor modulates ischemic stroke infarct volume.

Authors:  Han Kyu Lee; Sehoon Keum; Huaxin Sheng; David S Warner; Donald C Lo; Douglas A Marchuk
Journal:  J Clin Invest       Date:  2016-07-11       Impact factor: 14.808

4.  CD19 and CD32b differentially regulate human B cell responsiveness.

Authors:  Jodi L Karnell; Nazzareno Dimasi; Fredrick G Karnell; Ryan Fleming; Ellen Kuta; Mildred Wilson; Herren Wu; Changshou Gao; Ronald Herbst; Rachel Ettinger
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

Review 5.  Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.

Authors:  Theofanis Floros; Ahmad A Tarhini
Journal:  Semin Oncol       Date:  2015-06-03       Impact factor: 4.929

Review 6.  Role of IL-21 and IL-21 receptor on B cells in HIV infection.

Authors:  Suresh Pallikkuth; Anita Parmigiani; Savita Pahwa
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 7.  IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation.

Authors:  Xiao-Mei Deng; Shang-Xue Yan; Wei Wei
Journal:  Cell Mol Immunol       Date:  2014-08-04       Impact factor: 11.530

Review 8.  Plasma cell survival: The intrinsic drivers, migratory signals, and extrinsic regulators.

Authors:  Doan C Nguyen; Meixue Duan; Mohammad Ali; Ariel Ley; Ignacio Sanz; F Eun-Hyung Lee
Journal:  Immunol Rev       Date:  2021-08-01       Impact factor: 10.983

9.  Interleukin (IL)-21 promotes intestinal IgA response to microbiota.

Authors:  A T Cao; S Yao; B Gong; R I Nurieva; C O Elson; Y Cong
Journal:  Mucosal Immunol       Date:  2015-01-14       Impact factor: 7.313

10.  IL-21 enhances STAT3/Blimp-1 signaling pathway in B cells and contributes to plasma cell differentiation in newly diagnosed patients with myasthenia gravis.

Authors:  Yanan Xu; Xiaoyu Huang; Fengzhan Li; Tan Liu; Tingting Yang; Fei Chen; Jie Zhu; Meng Pan; Yong Zhang; Yuzhong Wang; Linlin Fu; Chenghua Xiao; Deqin Geng
Journal:  Immunol Res       Date:  2020-11-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.